InterCure Ltd. (INCR)
NASDAQ: INCR · Real-Time Price · USD
1.470
-0.050 (-3.29%)
Jun 5, 2025, 4:00 PM - Market closed
InterCure Employees
InterCure had 320 employees as of December 31, 2024. The number of employees increased by 50 or 18.52% compared to the previous year.
Employees
320
Change (1Y)
50
Growth (1Y)
18.52%
Revenue / Employee
$204,923
Profits / Employee
-$58,166
Market Cap
71.82M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
AbbVie | 55,000 |
INCR News
- 5 weeks ago - InterCure Announces FY2024 Results and Provides Q1 2025 Update: Revenue of NIS 239 Million and Adjusted EBITDA of NIS 24 Million, Strong Start to 2025 - PRNewsWire
- 4 months ago - InterCure Names Alexander Rabinovich as Chairman Replacing Ehud Barak - PRNewsWire
- 5 months ago - InterCure has Secured Funding of NIS 66M to support the recovery of Nir Oz Facility - PRNewsWire
- 9 months ago - Are Investors Missing The Forest? 35% Stock Drop Masks The International Potential Of This Weed Company - Benzinga
- 10 months ago - InterCure Announces First Half of 2024 Results: Revenue of NIS 126 million and Adjusted EBITDA of NIS 21 million - GlobeNewsWire
- 10 months ago - InterCure Announces Expansion of its Strategic partnership with Cookies to Germany - Business Wire
- 1 year ago - InterCure: A Cannabis Industry Leader Still Flying Under The Radar - Seeking Alpha
- 1 year ago - InterCure to Participate in Canaccord Genuity's 8th Annual Global Cannabis Conference - Business Wire